Loading...
Elkem ASA
ELKEF•PNK
Basic Materials
Chemicals - Specialty
$2.41
$0.00(0.00%)
Elkem ASA (ELKEF) Financial Performance & Income Statement Overview
Review Elkem ASA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-48.17%
↓ 48.17%
Operating Income Growth
24.49%
↑ 24.49%
Net Income Growth
577.78%
↑ 577.78%
Operating Cash Flow Growth
-32.47%
↓ 32.47%
Operating Margin
5.91%
↑ 5.91%
Gross Margin
50.13%
↑ 50.13%
Net Profit Margin
2.92%
↑ 2.92%
ROE
2.82%
↑ 2.82%
ROIC
3.92%
↑ 3.92%
Elkem ASA (ELKEF) Income Statement & Financial Overview
Review Elkem ASA's (ELKEF) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $4.22B | $4.30B | $7.73B | $8.26B |
Cost of Revenue | $1.93B | $1.97B | $3.87B | $4.45B |
Gross Profit | $2.29B | $2.33B | $3.85B | $3.80B |
Gross Profit Ratio | $0.54 | $0.54 | $0.50 | $0.46 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $1.30B |
Operating Expenses | $1.86B | $2.00B | $3.32B | $3.60B |
Total Costs & Expenses | $3.79B | $3.96B | $7.26B | $8.05B |
Interest Income | $16.00M | $31.00M | $32.00M | $15.00M |
Interest Expense | $159.00M | $198.00M | $222.00M | $178.00M |
Depreciation & Amortization | $717.00M | $801.00M | $681.00M | $625.00M |
EBITDA | $1.15B | $1.32B | $1.18B | $1.02B |
EBITDA Ratio | $0.27 | $0.31 | $0.15 | $0.12 |
Operating Income | $432.00M | $339.00M | $470.00M | $207.00M |
Operating Income Ratio | $0.10 | $0.08 | $0.06 | $0.03 |
Other Income/Expenses (Net) | -$160.00M | -$15.00M | -$201.00M | -$218.00M |
Income Before Tax | $272.00M | $324.00M | $269.00M | -$11.00M |
Income Before Tax Ratio | $0.06 | $0.08 | $0.03 | -$0.001 |
Income Tax Expense | $115.00M | $77.00M | $155.00M | $892.00M |
Net Income | -$212.00M | -$19.00M | $92.00M | $854.00M |
Net Income Ratio | -$0.05 | -$0.004 | $0.01 | $0.10 |
EPS | -$0.33 | -$0.03 | $0.15 | $1.35 |
Diluted EPS | -$0.33 | -$0.03 | $0.15 | $1.35 |
Weighted Avg Shares Outstanding | $634.17M | $634.17M | $634.00M | $633.96M |
Weighted Avg Shares Outstanding (Diluted) | $634.17M | $634.17M | $634.00M | $634.02M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan